Brief: aTyr Pharma Q3 Net Income USD -11.342 Million
09/11/2023 21:00
Nov 09 (Reuters) - aTyr Pharma Q3 basic EPS USD -0.2. * Q3 operating expenses USD 12.968 million * Q3 income from operations USD -12.615 million
Recent news on aTyr Pharma
See all newsBrief: Atyr Pharma Announces Research Collaboration With Montefiore Einstein
U.S. STOCKS ON THE MOVE-Charles River, Oracle, TD Synnex
US STOCKS ON THE MOVE-Charles River, Oracle, TD Synnex
U.S. STOCKS ON THE MOVE-CoreWeave, Versant Media, BlackBerry
aTyr rises as FDA aligns on late-stage lung disease study plan